D-galactosyl-1,1' N-lauroyl-D-erythro-sphingosine, also known by its CAS number 41613-14-3, is a glycosphingolipid that plays a significant role in cellular processes, particularly in the nervous system. This compound features a sphingosine backbone, which is a key structural component of sphingolipids, and is characterized by the presence of a galactose sugar moiety linked to the sphingosine via a glycosidic bond. The N-lauroyl group indicates the presence of a lauric acid moiety, contributing to the amphiphilic nature of the molecule, which allows it to interact with both hydrophilic and hydrophobic environments. D-galactosyl-1,1' N-lauroyl-D-erythro-sphingosine is involved in cell signaling and recognition processes, particularly in the context of neuronal function and development. Its unique structure and properties make it a subject of interest in biochemistry and pharmacology, especially in studies related to neurodegenerative diseases and cellular membrane dynamics.

D-galactosyl--1,1' N-lauroyl-D-erythro-sphingosine

41613-14-3: D-galactosyl-1,1' N-lauroyl-D-erythro-sphingosine, also known by its CAS number 41613-14-3, is a glycosphingolipid that plays a significant role in cellular processes, particularly in the nervous system. This compound features a sphingosine backbone, which is a key structural component of sphingolipids, and is characterized by the presence of a galactose sugar moiety linked to the sphingosine via a glycosidic bond. The N-lauroyl group indicates the presence of a lauric acid moiety, contributing to the amphiphilic nature of the molecule, which allows it to interact with both hydrophilic and hydrophobic environments. D-galactosyl-1,1' N-lauroyl-D-erythro-sphingosine is involved in cell signaling and recognition processes, particularly in the context of neuronal function and development. Its unique structure and properties make it a subject of interest in biochemistry and pharmacology, especially in studies related to neurodegenerative diseases and cellular membrane dynamics.

Dodecanoyl-Galactosylceramide

C12 Galactosylceramide, a sphingolipid, curbs IL-4 in T cells by 53.84% at 10 μM, thwarts HPV-16 tumors, cuts recurrence, and aids lupus mice.

CAS 41613-14-3

D-galactosyl--1,1' N-lauroyl-D-erythro-sphingosine

Dodecanoyl-Galactosylceramide

Ref: 48-56-2062

C12 Galactosylceramide (d18:1/12:0)

Ref: TM-T36858